Remove Clinical Supply Remove Drug Development Remove Drug Research
article thumbnail

Overcoming inefficiencies to improve access to cell and gene therapy 

Drug Discovery World

Repercussions of the Covid-19 pandemic The idea that the Covid-19 pandemic dramatically affected the CGT supply chain and upturned CGT manufacturing has dominated the conversation in the biotech sector 3. But now, the increased efficiency is likely making drug development cheaper.

Therapies 130